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there is fever or hypothermia, tachycardia, tachypnea,
leukocytosis or leucopenia and elevated CRP serum levels.
The diagnosis of sepsis requires evidence of infection.
Procalcitonin (PCT) serum levels are elevated only in septic
condition.
Objective: To correlate PCT with CRP, white blood cells
(WBC) and temperature (0T) of patients with SIRS in order
to conclude if PCT serum levels can attribute to the decision
if empirical antibiotic treatment should be administered
or not.
Material and Method: Ninety nine patients with SIRS were
enrolled in the study. PCT, CRP and 0T were determined.
The patients were divided in two groups. The ﬁrst group
consisted of patients with PCT 1 ng/ml and the other
group by patients with PCT> 1 ng/ml. The second group
was assumed as more susceptible to sepsis. We performed
Spearman correlation between PCT serum levels and CRP,
WBC and temperature (statistical signiﬁcance a = 0.05).
Results: In 54 patients with PCT 1 ng/ml there was no
statistical signiﬁcant correlation. On the other hand in the
remaining 45 patients with PCT> 1 ng/ml there was found
statistically signiﬁcant positive correlation (p < 0.05). Six of
the 54 while having normal PCT 1 ng/ml they had CRP
20mg/ml, WBC 20,000/mm3 and ºT 38.2.
Conclusions: The administration of antibiotics to the
patients with PCT 1 ng/ml would be unnecessary. The
patients with PCT >1 ng/ml should be given empirical
treatment especially to patients with PCT 5 ng/ml even
with negative blood cultures.
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Background: Chronic liver injury is caused by a variety of
injuries, including viral hepatitis, alcohol and drug abuse,
and autoimmune hepatitis. Liver ﬁbrosis is a process of
chronic liver injuries, characterized by increased synthesize
and decreased degradation of extracellular matrix (ECM),
ECM deposition in the liver and altered the normal liver
architecture and function. The present study aims the
changes of liver tissue NF-úB pathway and apoptosis-related
genes in experimental mice hepatic ﬁbrosis.
Methods: C57BL6/J mice were divided into model group
and control group, two group mice were injected with CCL4
or Sodium Chloride for 8 weeks to induce hepatic ﬁbrosis.
Blood and liver tissue was harvested from the mice. The
expression of a-SMA, NF-úB/IúBp65 and apoptosis-related
genes caspases3, Bcl-2/Bax in liver tissue was measured by
immunohistochemistry and RT-PCR assay. Serum ALT and HA
were measured.
Result: CCL4 induced hepatic ﬁbrosis models showed
increased serum ALT and HA levels, and progressive hepatic
injury including inﬂammatory inﬁltration and ﬁbrosis, which
associated with enhanced a-SMA, NF-úB, IúBP65 protein and
gene expression. Apoptosis-related gene bax expression was
increased, bcl-2 expression was decreased, caspases3 pro-
tein and gene expression were up-regulated. These effects
were associated with repressed hepatic HSC activation.
Conclusion: Our results demonstrate that NF-úB/IúB signal
pathway and apoptosis-related genes caspases3, bcl-2/bax
play a critical role in the progression of hepatic ﬁbrosis. It
could be useful targets for ﬁbrosis therapy.
Poster Session Fungal Infections
PP-061 Isolated cerebral mucormycosis refractory
to amphotericin B with good response to
posaconazole
F. Abbasi1 *, M. Mardani2. 1Bushehr University of Medical
Sciences, Bushehr, Iran, 2Infectious Disease and Tropical
Medical Research Center, Shaheed Besheshti Medical
University, Tehran, Iran
Introduction: Mucormycosis is a rare opportunistic infec-
tion, usually associated with immunocompromised states.
Several conditions such as hematologic malignancy, solid
organ transplantation, diabetes mellitus, corticosteroid
therapy, or chemotherapy predispose patients to infection.
It can produce an aggressive and sometimes fatal infection.
Cerebral mucormycosis is an acute life-threatening disease.
Early inﬁltration of the infectious agent into the central
nervous system may result in septic thrombosis of
the cavernous sinus, mycotic meningoencephalitis, brain
infarctions as well as intracerebral and subarachnoidal
hemorrhages.
Case Description: The patient was a 46 year-old woman
known case of diabetes mellitus with chief complaint
of headache, fever and swelling of right posterior
auricular area with erythema and hotness. Brain CT scan
was performed that showed a brain abscess in right
temporoparietal lobe. Smear of drained abscess showed
broad nonseptated hyphae and culture result was mucoral
agent. Amphotericin B was started. Despite several days
after amphotericin B infusion, fever continued and ESR
did not change. Amphotericin B was discontinued and
posaconazole was started. Fever disappeared and ESR
decreased and the patient was discharged with good
general condition. Isolated cerebral mucormycosis is a
rare and life threatening presentation of mucormycosis.
Resistance to amphotericin B is increasing in mucoral
agents. Mucormycosis has a good response to posaconazole.
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Objectives: Mucormycosis is an aggressive fungal disease
that involves the paranasal sinuses, orbit, central nervous
system and other organs. This infection usually occurs
secondary to immune suppression, diabetic ketoacidosis,
and prolonged use of antibiotics, steroids, and cytotoxic
drugs. Management of the condition consists of treatment of
the underlying disease and surgical debridement combined
with intravenous antifungal agents.
Methods: In a retrospective study we evaluated nine
cases of mucormycosis in several tertiary care hospitals
in Iran during several years. Clinical manifestations,
diagnosis including laboratory and radiologic study,
management including surgical and medical interventions
were evaluated.
Results: In this study there were six cases of rhinocerebral
mucormycosis, one case of pulmonary mucormycosis, one
case of pelvic mucormycosis and one case of isolated
cerebral mucormycosis. Risk factor for most of our
patients was diabetes mellitus. We use amphotericin B and
posaconazole as medical therapy. Surgical intervention and
radical debridement was performed for all of patients. Five
cases (55.5%) of our patients survived. The patients that
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expired were those who developed cerebritis, meningitis or
brain abscess.
Conclusion: Mucormycosis is a rare but usually fatal fungal
infection. High index of suspicion, early diagnosis, and
combination treatment with antifungal agents and surgical
debridement may improve the prognosis of this serious
infection. Resistance to amphotericin B is increasing in
mucoral agents. Mocurmycosis has a good response to
posaconazole.
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Background: The morbidity and mortality rates are
signiﬁcantly increased in immunodepressed patients as a
result of severe fungal infections. The present study aimed
to conduct a retrospective investigation of the etiology of
fungal infections in a group of immunodepressed patients.
Methods: The authors have retrospectively analyzed
the hospital records of 79 immunodepressed patients
(44 males, 35 females) admitted at the Department
of Infectious Diseases from Timisoara. The positive
diagnosis was established based on physical examination
(fever, weight loss, white depots on tongue, headache,
anorexia, asthenia) and laboratory data (leukocyte count,
erythrocyte sedimentation rate, C reactive protein, titre
of antistreptolysin O antibodies, electrophoresis, blood
culture, sputum culture, ELISA, Western blot, glossal
exudate and CHROM-AGAR or Sabouraud medium culture).
The identiﬁcation has been made by API Candida system,
ATB Fungus 2 system testing for antifungal sensibility and
direct microscopy examination of fungal specimens. The
data obtained was statistically processed with EpiInfo 5
program.
Results: The study group was distributed as follows:
16 patients had diabetes mellitus, 24 had chronic hepatitis,
12 had liver cirrhosis, 12 had hematological malignancies,
6 had pulmonary tuberculosis, 5 had breast cancer and 4
had pulmonary cancer. Fungal infections were diagnosed in
65 patients (82.27%): 50 patients (76.92%) presented glossal
candidiasis, 12 (18.46%) had oropharingeal candidiasis, and
3 (4.61%) had esophageal candidiasis. There have been
isolated 40 strains of Candida albicans and 25 strains of
Candida non-albicans (p = 0.03) among which 10 strains of
Candida glabrata, 9 strains of Candida keﬁr and 6 strains
of Candida parapsilosis. Out of the 40 strains of Candida
albicans, 26 were resistant to ﬂuconazole (p = 0.04) but all
were sensitive to itraconazole.
Conclusion: The knowledge of the etiological spectrum of
fungal infections in immunocompromised patients allows
the proper implementation of the antifungal treatment and
prophylaxis measures thus leading to satisfying results.
PP-064 Cutaneous zygomycosis of the scalp:
a case report and review of the literature
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Background: The incidence of the life-threatening invasive
fungal infection, Zygomycosis, has been increasing over
the past two decades. Cutaneous Zygomycosis represents
the third most common type, following Rhinocerebral
and Pulmonary forms. It can be superﬁcial, invasive or
disseminated. Primary and isolated Scalp involvement is
very rare.
Method: We report a case of scalp Zygomycosis in a diabetic
patient presented with large eschar. He was treated by
surgical excision, skin graft and antifungal therapy using
Amphotericin B lipid complex for one month followed by
Posaconazole for three months.
Results: He was successively cured with no evidence of
recurrence for one year.
Conclusion: Cutaneous Zygomycosis requires high index of
clinical suspicion for timely diagnosis through early skin
biopsy for histopathology and culture particularly if there
is a skin necrosis. Treatment consists of combination of
prompt surgical intervention and antifungal therapy.
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Aim: To establish a murine model of invasive pulmonary
aspergillosis and to analyze its reserch value.
Methods: Mice were immunosuppressed with cyclosphos-
phamide by intraperitoneal injections and in the process
routine blood test were monitored. Invasive pulmonary
aspergillosis was induced by inoculation of Aspergillus
fumigatus spore suspension with self-made tracheal
intubation. Mice were sacriﬁced on day 1, 3, 5, 7 after
inoculation and their lung tissues were was cultured and
histopathologically analyzed.
Results: Mice shows a loss of weight and depression after
a series of different dose of cyclosphosphamide injection.
Routine blood test shows a signiﬁcant decrease of white
blood cells. Nutrogranulocytes and lymphocytes can’t be
distinguished. By observing pathological slices, we can
see lung tissue lesion aggrates gradually after inoculation.
Haemorrhage and cellulose exsudation is obviously seen;
sporus aggregat and germinate. As a result, alveoli are
destroyed diffusely and a large area of lung edema
happened.
Conclusions: A murine model of invasive pulmonary
aspergillosis is succes sfully established, which will de a
reference of further studies of aspergillosis pathogenesis
and pathophysiology, in addition to antifungal agent
pharmacodynamics.
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Mucormycosis invasive fungal infection affecting any
organ. Over 50% of cases are rhinocerebral involvement
requiring emergent, aggressive, disﬁguring facial surgery.
Mucormycosis affects immunocompromised patients or
those with metabolic abnormalities.
51yo woman presented with lethargy, decreased PO intake
for 5 days. PMH: DM, HTN (both non-compliant), CVA, PE,
DVT, IVC ﬁlter.
Patient underwent procedure for dental abscess in right
maxilla 5 days before admission, was on amoxicillin, denied
recent fevers, chills. She hasn’t been taking insulin for
unknown time.
On examination: right-sided facial swelling, numbness, right
eye closed with surrounding erythema, proptosis, diplopia,
decreased visual acuity. Nasal mucosa didn’t reveal black
turbinates.
